http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-0109863-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b057403341b8246c1ce2d2b2a2201195
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-46
filingDate 2001-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8eeb09a985e8b082f0702faf78a06af2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f34a1525afe1bfae83545e255f252ee6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6d8b9e9e4ab8e5c645ed4958ce01cc2
publicationDate 2004-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-0109863-A
titleOfInvention Prostaglandin e1-containing topical compositions
abstract "TOPIC COMPOSITIONS CONTAINING PROSTAGLANDINE AND ~ 1 ~". A semisolid consistency topical composition suitable for transdermal application of prostaglandin E1- is provided. The composition comprises prostaglandin E1, a penetration enhancer, a polysaccharide gum, a lipophilic compound, and an acid buffer system. The skin penetration enhancer is an acid addition salt of an alkyl-2- (substituted amino) alkanoate ester, (substituted amino) alkanol alkanoate, or a mixture thereof. The lipophilic compound may be a C 1 to C 8 aliphatic alcohol, a C 8 to C 30 aliphatic ester, or a mixture thereof. The composition includes a buffer system capable of providing a buffered pH value for said composition in the range of from about 3 to about 7.4.
priorityDate 2000-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590105
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280723
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416290180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1030

Total number of triples: 37.